skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8121

Management of intracerebral hemorrhage

(2278) Views  (748) Full article downloads

Authors: Ramandeep Sahni, Jesse Weinberger

Published Date November 2007 Volume 2007:3(5) Pages 701 - 709
DOI: http://dx.doi.org/10.2147/VHRM.S

Ramandeep Sahni, Jesse Weinberger

Department of Neurology, Mount Sinai School of Medicine, New York, NY, USA

Abstract: Currently, intracerebral hemorrhage (ICH) has the highest mortality rate of all stroke subtypes (Counsell et al 1995; Qureshi et al 2005). Hematoma growth is a principal cause of early neurological deterioration. Prospective and retrospective studies indicate that up to 38% hematoma expansion is noted within three hours of ICH onset and that hematoma volume is an important predictor of 30-day mortality (Brott et al 1997; Qureshi et al 2005). This article will review current standard of care measures for ICH patients and new research directed at early hemostatic therapy and minimally invasive surgery.

Keywords: ICH, hemostatic therapy, recombinant factor VII, surgical management
  • Join ISVH

    Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)

  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University